Digital Pathology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Digital Pathology Market is segmented by Product (Scanner, Software, Storage Systems, and Other Products), Application (Disease Diagnosis, Drug Discovery, and Education and Training), End User (Pharmaceutical, Biotechnology, Companies, and CROs, Hospital and Reference Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 11.97 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The increasing number of teleconsultations, rising adoption of digital pathology to enhance lab efficiency, and increasing application in drug discovery and companion diagnostics are driving the digital pathology market. Moreover, the investment in laboratory expansion and market penetration of key manufacturers are likely to propel the market growth.

Teleconsultation aims to omit geographical and functional distances between two or more geographically separated healthcare providers. It is defined as the consultation by remote telecommunications, primarily for the diagnosis or treatment of a patient at sites that are distant from the patients or primary physicians. Teleconsultation services are being implemented by several hospitals, primary healthcare physicians, private medical practices, and other medical units. Thus, it has proven to be feasible and effective, to potentially reduce costs, provide organizational benefits, and improve patient’s satisfaction.

The use of digital pathology in disease diagnosis is also increasing, due to the integration of digital pathology with digital tools, barcoding, specimen tracking, and digital dictation, which improves the safety, quality, and efficiency of disease diagnoses in pathology laboratories.

The market is also expected to be driven by the increasing adoption of telepathology, rising investment in healthcare in developed countries, market penetration of key manufacturers in the developing region, and an increasing focus on drug discovery.

Scope of the Report

As per the scope of the report, digital pathology includes the acquisition, management, sharing, and interpretation of pathology information, which include slides and data in a digital environment. The digital slides are created when glass slides are captured with a scanning device, to offer a high-resolution image to be viewed on a computer screen or mobile device.

By Product
Scanner
Software
Storage Systems
Other Products
By Application
Disease Diagnosis
Drug Discovery
Education and Training
By End User
Pharmaceutical, Biotechnology, Companies, and CROs
Hospital and Reference Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Disease Diagnosis is Expected to Grow the Fastest by Application, over the Forecast Period

For the diagnosis of diseases, digital pathology encompasses different technologies, which include laboratory management systems, digital dictation, dashboards and workflow management, digital image analysis, electronic specimen labeling and tracking, and synoptic reporting tools. Therefore, the integration of digital pathology, along with digital tools, barcoding, specimen tracking, and digital dictation, improves the safety, quality, and efficiency of disease diagnoses in pathology laboratories. Hence, owing to the advantages of using digital pathology for disease diagnoses, the market is expected to grow significantly, over the forecast period.

Number of infectious disease cases , by Disease, United States, 2017

Asia-Pacific is the Fastest-growing Region and is Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific digital pathology market is anticipated to exhibit the fastest CAGR during the forecast period, due to the proliferation of advanced imaging modalities in emerging economies, growing investments in the medical field, and the presence of untapped opportunities. Thus, the presence of a large target patient population and booming healthcare industry are encouraging the growth of the regional market.

North America is expected to dominate the overall market throughout the forecast period. The presence of high per capita healthcare expenditure, increasing investment from key players, and the well-established IT and healthcare infrastructure are some of the factors contributing to the growth of the market studied in the region.

Digital PathologyDigital Pathology Market- Growth Rate by Region  Market- Growth Rate by Region

Competitive Landscape

The key players in the digital pathology market are adopting strategies, such as mergers and acquisitions, technological developments, and geographical expansions, in order to capture a significant position. Several manufacturers are focusing on developing digital pathology scanners with high throughput, improved resolution, high magnification, and high-end microscopes with automated scanning, which are expected to drive the market growth during the forecast period.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Number of Tele-consultations

      2. 4.2.2 Rising Adoption of Digital Pathology to Enhance Lab Efficiency

      3. 4.2.3 Increasing Application in Drug Discovery and Companion Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Concerns for Primary Diagnosis

      2. 4.3.2 Lack of Standard Guidelines for Digital Pathology

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Scanner

      2. 5.1.2 Software

      3. 5.1.3 Storage Systems

      4. 5.1.4 Other Products

    2. 5.2 By Application

      1. 5.2.1 Disease Diagnosis

      2. 5.2.2 Drug Discovery

      3. 5.2.3 Education and Training

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical, Biotechnology, Companies, and CROs

      2. 5.3.2 Hospital and Reference Laboratories

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 3DHistech Ltd

      2. 6.1.2 Hamamatsu Photonics KK

      3. 6.1.3 Danaher Corporation (Leica Biosystems Nussloch GmbH)

      4. 6.1.4 Mikroscan Technologies Inc.

      5. 6.1.5 Nikon Corporation

      6. 6.1.6 Olympus Corporation

      7. 6.1.7 Koninklijke Philips NV

      8. 6.1.8 F. Hoffmann-La Roche AG(Ventana Medical Systems Inc.)

      9. 6.1.9 Visiopharm AS

      10. 6.1.10 Proscia Inc.

      11. 6.1.11 Sectra AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Digital Pathology Market market is studied from 2018 - 2026.

The Digital Pathology Market is growing at a CAGR of 11.97% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

3DHistech Ltd, Mikroscan Technologies Inc., Nikon Corporation, Hamamatsu Photonics KK, Leica Biosystems Nussloch GmbH are the major companies operating in Digital Pathology Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!